Literature DB >> 10706966

Induction of a protection against S. mansoni with a MAP containing epitopes of Sm37-GAPDH and Sm10-DLC. Effect of coadsorption with GM-CSF on alum.

L Argiro1, S Henri, H Dessein, B Kouriba, A J Dessein, A Bourgois.   

Abstract

Studies of anti-S. mansoni immunological responses in individuals living in endemic areas identified immunogens (Sm37-GAPDH and Sm10-DLC) with vaccine candidate properties. Analysis of the epitopes of these immunogens indicated that: (i) Sm37-5 is a major B-cell epitope of Sm37-GAPDH and the IgG antibody reactivity toward this determinant is associated with resistance to reinfection; (ii) Sm10-T is a T-cell epitope of the major T-cell immunogen Sm10-DLC. This led us to test a multiple antigen peptide (MAP) containing Sm37-5 and Sm10-T as an anti-schistosome vaccine. This MAP induced a significant protective immune response in mice when injected in Freund's adjuvant or coadsorbed with GM-CSF on aluminium hydroxide. In the latter case the physical link between the cytokine and the antigen via the coadsorption on alum was necessary to obtain a protective response. Results of the antibody response indicated that when the MAP and GM-CSF were coadsorbed on alum, the antibody response against the Sm10-T epitope located in the NH(2)-terminal position was significantly amplified up to 30% of the anti-Sm37-5 response.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10706966     DOI: 10.1016/s0264-410x(99)00523-x

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  7 in total

1.  Screening the Schistosoma mansoni transcriptome for genes differentially expressed in the schistosomulum stage in search for vaccine candidates.

Authors:  Leonardo P Farias; Cibele A Tararam; Patricia A Miyasato; Milton Y Nishiyama; Katia C Oliveira; Toshie Kawano; Sergio Verjovski-Almeida; Luciana Cezar de Cerqueira Leite
Journal:  Parasitol Res       Date:  2010-09-18       Impact factor: 2.289

2.  Identification of paramyosin T cell epitopes associated with human resistance to Schistosoma mansoni reinfection.

Authors:  C T Fonseca; E Cunha-Neto; A C Goldberg; J Kalil; A R de Jesus; E M Carvalho; R Correa-Oliveira; J Hammer; J Sidney; A Sette; S C Oliveira
Journal:  Clin Exp Immunol       Date:  2005-12       Impact factor: 4.330

3.  Echinococcus multilocularis: immunity response to purified alkaline phosphatase in BALB/c mice.

Authors:  Nassima Issaadi; Marion Fraize; Samira Azzouz; Anne-Françoise Pétavy; Marie-Elizabeth Sarciron
Journal:  Parasitol Res       Date:  2005-12-07       Impact factor: 2.289

4.  Recent Advances in Schistosomiasis.

Authors:  G. Richard Olds; Srinivasan Dasarathy
Journal:  Curr Infect Dis Rep       Date:  2001-02       Impact factor: 3.725

5.  The nature and combination of subunits used in epitope-based Schistosoma japonicum vaccine formulations affect their efficacy.

Authors:  Xuefeng Wang; Lei Zhang; Ying Chi; Jason Hoellwarth; Sha Zhou; Xiaoyun Wen; Lei He; Feng Liu; Calvin Wu; Chuan Su
Journal:  Parasit Vectors       Date:  2010-11-19       Impact factor: 3.876

6.  Suppression of the Insulin Receptors in Adult Schistosoma japonicum Impacts on Parasite Growth and Development: Further Evidence of Vaccine Potential.

Authors:  Hong You; Geoffrey N Gobert; Pengfei Cai; Rong Mou; Sujeevi Nawaratna; Guofu Fang; Francois Villinger; Donald P McManus
Journal:  PLoS Negl Trop Dis       Date:  2015-05-11

Review 7.  Do schistosome vaccine trials in mice have an intrinsic flaw that generates spurious protection data?

Authors:  R Alan Wilson; Xiao-Hong Li; William Castro-Borges
Journal:  Parasit Vectors       Date:  2016-02-17       Impact factor: 3.876

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.